HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)

Chronic glomerulonephritis characterized histologically by proliferation of MESANGIAL CELLS, increase in the MESANGIAL EXTRACELLULAR MATRIX, and a thickening of the glomerular capillary walls. This may appear as a primary disorder or secondary to other diseases including infections and autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Various subtypes are classified by their abnormal ultrastructures and immune deposits. Hypocomplementemia is a characteristic feature of all types of MPGN.
Also Known As:
Membranoproliferative Glomerulonephritis, Type II; Dense Deposit Disease; Mesangiocapillary Glomerulonephritis; Glomerulonephritis, Membranoproliferative; DDD MPGNII; Glomerulonephritis, Hypocomplementemic; MPGNII; Membranoproliferative Glomerulonephritis Type II; Membranoproliferative Glomerulonephritis, Type I; Membranoproliferative Glomerulonephritis, Type III; Mesangiocapillary Glomerulonephritis, Type I; Mesangiocapillary Glomerulonephritis, Type II; Subendothelial Membranoproliferative Glomerulonephritis; Type II MPGN; DDD MPGNIIs; Glomerulonephritides, MPGN Membranoproliferative; Glomerulonephritides, Membranoproliferative; Glomerulonephritis, MPGN Membranoproliferative; Glomerulopathies, Complement 3; Glomerulopathy, Complement 3; Hypocomplementemic Glomerulonephritides; Hypocomplementemic Glomerulonephritis; MPGN Membranoproliferative Glomerulonephritides; MPGN, Type II; MPGNII, DDD; MPGNIIs; Membranoproliferative Glomerulonephritides; Membranoproliferative Glomerulonephritides, MPGN; Membranoproliferative Glomerulonephritis, MPGN; Membranoproliferative Glomerulonephritis, Subendothelial; Mesangiocapillary Glomerulonephritides; Type II MPGNs; C3G Complement 3 Glomerulopathy; Complement 3 Glomerulopathies; Complement 3 Glomerulopathy; Glomerulonephritis, Mesangiocapillary; MPGN Membranoproliferative Glomerulonephritis
Networked: 1224 relevant articles (44 outcomes, 78 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Proteinuria
2. Cryoglobulinemia
3. Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
4. Nephrotic Syndrome (Syndrome, Nephrotic)
5. Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)

Experts

1. Sethi, Sanjeev: 27 articles (01/2022 - 09/2004)
2. Fervenza, Fernando C: 18 articles (01/2022 - 04/2010)
3. Zipfel, Peter F: 18 articles (01/2022 - 12/2002)
4. Smith, Richard J H: 18 articles (01/2021 - 09/2007)
5. Alpers, Charles E: 16 articles (01/2022 - 04/2002)
6. Pickering, Matthew C: 16 articles (01/2022 - 08/2002)
7. Appel, Gerald B: 12 articles (01/2022 - 01/2004)
8. Bomback, Andrew S: 11 articles (01/2022 - 03/2011)
9. Cook, H Terence: 11 articles (01/2022 - 08/2002)
10. Józsi, Mihály: 10 articles (01/2021 - 01/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Membranoproliferative Glomerulonephritis:
1. SteroidsIBA
2. Prednisone (Sone)FDA LinkGeneric
3. Cyclosporine (Ciclosporin)FDA LinkGeneric
4. Adrenal Cortex Hormones (Corticosteroids)IBA
5. Mycophenolic Acid (Cellcept)FDA LinkGeneric
6. Antiviral Agents (Antivirals)IBA
7. eculizumabFDA Link
8. Rituximab (Mabthera)FDA Link
9. Immunoglobulins (Immunoglobulin)IBA
10. InterferonsIBA

Therapies and Procedures

1. Therapeutics
2. Transplantation
3. Drug Therapy (Chemotherapy)
4. Plasma Exchange
5. Surgical Portasystemic Shunt (Portosystemic Shunt)